EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GARAK YARAGHI M.; KIANJOO M.; MORTAZAVI M.; SARAFZADEGAN NAZILA; SHEMIRANI H.; SHAHPARIAN M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS) Year:2001 | Volume:6 | Issue:3 Page(s): 228-233

Download Full-Text

Persian Verion

View:

888

Download:

Cites:

Information Journal Paper

Title

EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL

Author(s)

Keywords

ACUTE MYOCARDIAL INFARCTIONQ3

CORONARY ARTERY DISEASEQ3

GLUCOSEQ3

INSULINQ3

POTASSIUMQ3

MAGNESIUMQ4

THROMBOLYTIC THERAPYQ3

MORTALI1YQ3

MORBIDITYQ3

DOUBLE BLIND RANDOMIZED CLINICAL TRIALQ3

Abstract

Introduction. Although common theraputic methods for myocardial infarction are conducted, mortality and MORBIDITY of this disease are high, yet. Therefore, finding a new economical therapies such as metabolic modulation of ischemic myocardial muscle with THROMBOLYTIC THERAPY can somehow improves this situation. This study investigates the effect of GLUCOSE, INSULIN, POTASSIUM (GIK) and Magnasium (Mg) along with THROMBOLYTIC THERAPY on such patients.Methods. In this DOUBLE BLIND RANDOMIZED CLINICAL TRIAL study, two hundred patients, with myocardial infarction who have THROMBOLYTIC THERAPY indication, were randomly selected and divided into 6 groups of 30. Each group were treated based on their specific treatment protocol. Finally, people in the first five groups were compared with the sixth group about mortality and MORBIDITY both in hospital and during 3 and 6 months after their treatment.Results were statistically analysed based on the questionares.Results. The patients aged from 58.77±2.6. From these people 77 percent were men. Heart failure and in hospital arrhythmia and ejection fraction of the people at the time of discharge in the five groups which recived metabolic intervention in same way were had better conclusion than the control group. In-hospital mortality and MORBIDITY was not significantly different in any of the groups. Three month later, mortality and MORBIDITY of the group who received GIK and Mg was significantly less than the control group. After six month none of the patients who received high dose GIK and Mg along with THROMBOLYTIC THERAPY, died, while at the same time the rate of death in the control group was 44.4 percent.Discussion. The results showed that GIK infusion and Mg along with THROMBOLYTIC THERAPY can significantly decrease the mortality and MORBIDITY of the patients with myocardial infarction either in hospital or after a long time.

Cites

No record.

References

No record.

Cite

APA: Copy

GARAK YARAGHI, M., KIANJOO, M., MORTAZAVI, M., SARAFZADEGAN, NAZILA, SHEMIRANI, H., & SHAHPARIAN, M.. (2001). EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 6(3), 228-233. SID. https://sid.ir/paper/26539/en

Vancouver: Copy

GARAK YARAGHI M., KIANJOO M., MORTAZAVI M., SARAFZADEGAN NAZILA, SHEMIRANI H., SHAHPARIAN M.. EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2001;6(3):228-233. Available from: https://sid.ir/paper/26539/en

IEEE: Copy

M. GARAK YARAGHI, M. KIANJOO, M. MORTAZAVI, NAZILA SARAFZADEGAN, H. SHEMIRANI, and M. SHAHPARIAN, “EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 6, no. 3, pp. 228–233, 2001, [Online]. Available: https://sid.ir/paper/26539/en

Related Journal Papers